Real-World Effectiveness of Benralizumab Among Patients with Asthma and Concomitant Chronic Obstructive Pulmonary Disease.

Saved in:
Bibliographic Details
Title: Real-World Effectiveness of Benralizumab Among Patients with Asthma and Concomitant Chronic Obstructive Pulmonary Disease.
Authors: Carstens DD; Respiratory & Immunology, AstraZeneca, Wilmington, DE, USA., Maselli DJ; Division of Pulmonary Diseases & Critical Care, University of Texas Health, San Antonio, TX, USA., Cook EE; Health Economic and Outcomes Research, Analysis Group, Boston, MA, USA., Mu F; Health Economic and Outcomes Research, Analysis Group, Boston, MA, USA., Chen J; Health Economic and Outcomes Research, Analysis Group, Boston, MA, USA., Yang D; Health Economic and Outcomes Research, Analysis Group, Boston, MA, USA., DeMartino JK; Respiratory & Immunology, AstraZeneca, Wilmington, DE, USA., Chung Y; Respiratory & Immunology, AstraZeneca, Wilmington, DE, USA.
Source: International journal of chronic obstructive pulmonary disease [Int J Chron Obstruct Pulmon Dis] 2024 Aug 07; Vol. 19, pp. 1813-1818. Date of Electronic Publication: 2024 Aug 07 (Print Publication: 2024).
Publication Type: Letter; Research Support, Non-U.S. Gov't
Journal Info: Publisher: DOVE Medical Press Country of Publication: New Zealand NLM ID: 101273481 Publication Model: eCollection Cited Medium: Internet ISSN: 1178-2005 (Electronic) Linking ISSN: 11769106 NLM ISO Abbreviation: Int J Chron Obstruct Pulmon Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1178-2005
DOI:10.2147/COPD.S468887